%0 Journal Article
%A Balaña, C
%A Alonso, M
%A Hernandez-Lain, A
%A Hernandez, A
%A Perez-Segura, P
%A Pineda, E
%A Ramos, A
%A Sanchez, A R
%A Teixidor, P
%A Verger, E
%A Benavides, M
%T SEOM clinical guidelines for anaplastic gliomas (2017).
%D 2017
%U http://hdl.handle.net/10668/11715
%X The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors.
%K Anaplastic astrocytoma
%K Anaplastic glioma
%K Anaplastic oligodendroglioma
%~